Molecular Recognition and In-Vitro-Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer-Reference-Cited by-同舟云学术

Molecular Recognition and In-Vitro-Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer

Published:2018-09 Issue: Volume:12 Page:758-768
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Zhang Hui,Wang Zhibo,Xie Lin,Zhang Yibin,Deng Tanggang,Li Jianglin,Liu Jing,Xiong Wei,Zhang Lei,Zhang Lin,Peng Bo,He Leye,Ye Mao,Hu Xiaoxiao,Tan Weihong

Funder

National Natural Science Foundation of China

Hunan Provincial Natural Science Foundation of China

Hunan Provincial Key Research and Development Plan

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference23 articles.

1. Renal cell carcinoma;Cairns;Cancer Biomark.,2010

2. International variations and trends in renal cell carcinoma incidence and mortality;Znaor;Eur. Urol.,2015

3. Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2;Bukowski;Cancer,1997

4. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma;Zisman;J. Clin. Oncol.,2002

5. Generating aptamers by cell-SELEX for applications in molecular medicine;Ye;Int. J. Mol. Sci.,2012

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A colorimetric and SERS dual-mode aptasensor for the detection of Shiga toxin type II based on Mn/Fe-MIL(53)@AuNSs;Talanta;2024-04

2. Evolution and Trends of Aptamers in Cancer Research: A Bibliometric Analysis of the Literature over the Last Decade;Current Medicinal Chemistry;2024-02-14

3. Moving towards Personalized Medicine—The Broad Use of Aptamers for Targeted Theranostic;Applied Sciences;2023-10-31

4. Chemical Amplification-Enabled Topological Modification of Nucleic Acid Aptamers for Enhanced Cancer-Targeted Theranostics;ACS Nano;2023-09-01

5. The Application of Aptamers in Renal Carcinoma;PROG BIOCHEM BIOPHYS;2023